Product highlights
- Indego Therapy is a separately named adjustable lower-limb powered clinical exoskeleton with custom sizing, training settings and performance analytics. The archive’s less-than-five-minute fitting claim is a setup claim, not a universal therapy throughput or clinical recovery result.
- Clinical US 043-016-001.A explicitly names Indego Therapy and gives 39 lbf (17.7 kgf) as printed device weight and 28.69 × 18.25 × 22.71 in (72.8 × 46.3 × 57.6 cm). The 250 lb wearer limit is separate, and the different Personal mass is not substituted.
- The Clinical safety table lists 159 Wh (4.9 Ah), four-hour operating time and four-hour charging. Exact operating-mode/test and charge-state conditions are unspecified; Personal Motion+ 90-minute/2,500-step language is not transferred.
- The Clinical US intended-use text excludes home/community use, sports and stair climbing. Its clinician-supervised role is separate from Personal use with a trained companion, and regulatory documents retain their date and indication scope.
- The current manufacturer site lists Indego Therapy under Past Products; the issuer’s report signed February 23, 2026 described it among revenue-generating products. This is a dated lifecycle difference, not proof of current availability or discontinuation of all service, and acquisition FAQ support intent does not establish a new-unit sales offer.
Product sources
- Ekso Bionics — official past-products archive: HULC, eLEGS, EksoGT, EksoVest and Indego Therapy · Manufacturer source · Checked 2026-11-02
- Ekso Bionics — Indego safety ZIP: Personal US 043-015-001.A and Clinical US 043-016-001.A; separate device specifications · Manufacturer source · Checked 2026-11-02
- Ekso Bionics — issuer 2025 Form 10-K signed February 23, 2026; dated products and conditional Nomad rollout · Manufacturer source · Checked 2026-11-02
Description
Ekso Indego Therapy is the separately named adjustable clinical lower-limb exoskeleton. The current site places it under Past Products, whereas the issuer’s February 23, 2026 report described product sales; this does not prove current new-device supply or cessation of support. Clinical US safety 043-016-001.A lists 39 lbf/17.7 kgf as printed device weight, 72.8 × 46.3 × 57.6 cm, four-hour operating time and four-hour charging. Wearer fitting and less-than-five-minute setup are separate from device geometry and standardized throughput. The clinical manual excludes home/community use, sports and stairs; Personal specifications are not inherited.
Specifications
Sources cover the marked fields only. Unmarked values have not been checked in this review; manufacturer figures are not independent test results.
| WeightSource review · | 39 lbf (17.7 kgf), as printed in Clinical US safety Rev A; not wearer mass or Personal-device weight |
| SizeSource review · | 28.69 × 18.25 × 22.71 in (72.8 × 46.3 × 57.6 cm), Clinical US safety Rev A; measurement posture unspecified |
| Battery LifeSource review · | 4 h operating time listed in Clinical US safety Rev A; mode/test conditions unspecified |
| Charging timeSource review · | 4 h listed in Clinical US safety Rev A; state-of-charge window unspecified |
| Drive modeSource review · | Clinician-configured powered lower-limb gait training with adjustable device settings and performance analytics |
| TerrainSource review · | Rehabilitation-institution use; Clinical US safety text excludes home/community use, sports and stair climbing |